Back
Türk Telekomünikasyon AS Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
67
TRKNY
Türk Telekomünikasyon AS
Last Price:
$3.00
Seasonality Move:
-0.9%
Sell
41
MNPR
Monopar Therapeutics, Inc.
Last Price:
$70.72
Seasonality Move:
25.93%
Buy
67
Türk Telekomünikasyon AS (TRKNY)
is a Buy
Is Türk Telekomünikasyon AS a Buy, Sell or Hold?
-
The current Türk Telekomünikasyon AS [TRKNY] share price is $3.00. The Score for TRKNY is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
TRKNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRKNY Stock Price Chart
What is Türk Telekomünikasyon AS's stock price today?
-
The Türk Telekomünikasyon AS share price today is $3.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRKNY is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $70.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
TRKNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 75.45 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.64 - 2.82) | Buy |
| Bollinger Bands (100): | (2.44 - 2.8) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.54 | Sell |
| Relative Strength Index (14 RSI): | 41.3 | Sell |
| Chaikin Money Flow: | 7856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.72 - 85.64) | Sell |
| Bollinger Bands (100): | (46.03 - 89.35) | Buy |
TRKNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.79 | Buy |
| 20-day SMA: | 2.74 | Buy |
| 50-day SMA: | 2.6 | Buy |
| 200-day SMA: | 2.74 | Buy |
| 8-day EMA: | 1.82 | Buy |
| 20-day EMA: | 0.94 | Buy |
| 50-day EMA: | 0.42 | Buy |
| 200-day EMA: | 0.11 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.44 | Sell |
| 20-day SMA: | 77.62 | Sell |
| 50-day SMA: | 81.13 | Sell |
| 200-day SMA: | 52.54 | Buy |
| 8-day EMA: | 71.33 | Sell |
| 20-day EMA: | 75.43 | Sell |
| 50-day EMA: | 76.56 | Sell |
| 200-day EMA: | 56.82 | Buy |
Türk Telekomünikasyon AS Earnings Growth & TRKNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Türk Telekomünikasyon AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||